Apollo Endosurgery Inc. (NASDAQ: APEN)’s stock price has increased by 0.30 compared to its previous closing price of 9.87. Despite this, the company has seen a fall of -0.50% in its stock price over the last five trading days.
Is It Worth Investing in Apollo Endosurgery Inc. (NASDAQ: APEN) Right Now?
Moreover, the 36-month beta value for APEN is 2.32.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
The public float for APEN is 38.37M and currently, short sellers hold a 1.61% of that float. On March 15, 2023, APEN’s average trading volume was 1.37M shares.
APEN’s Market Performance
APEN stock saw a decrease of -0.50% in the past week, with a monthly decline of -0.30% and a quarterly a decrease of -1.20%. The volatility ratio for the week is 0.33%, and the volatility levels for the last 30 days are 0.20% for Apollo Endosurgery Inc. (APEN). The simple moving average for the last 20 days is -0.35% for APEN stock, with a simple moving average of 41.24% for the last 200 days.
Analysts’ Opinion of APEN
Many brokerage firms have already submitted their reports for APEN stocks, with Stifel repeating the rating for APEN by listing it as a “Hold.” The predicted price for APEN in the upcoming period, according to Stifel is $10 based on the research report published on January 04th of the current year 2023.
Lake Street, on the other hand, stated in their research note that they expect to see APEN reach a price target of $10, previously predicting the price at $14. The rating they have provided for APEN stocks is “Hold” according to the report published on November 30th, 2022.
Cowen gave a rating of “Outperform” to APEN, setting the target price at $13 in the report published on December 15th of the previous year.
APEN Trading at -0.06% from the 50-Day Moving Average
After a stumble in the market that brought APEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.88% of loss for the given period.
Volatility was left at 0.20%, however, over the last 30 days, the volatility rate increased by 0.33%, as shares sank -0.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.50% lower at present.
During the last 5 trading sessions, APEN fell by -0.50%, which changed the moving average for the period of 200-days by +135.15% in comparison to the 20-day moving average, which settled at $9.93. In addition, Apollo Endosurgery Inc. saw -0.70% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for APEN
Equity return is now at value -78.70, with -33.00 for asset returns.
To wrap up, the performance of Apollo Endosurgery Inc. (APEN) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.